Back to Search Start Over

A multimodal and integrated approach to interrogate human kidney biopsies with rigor and reproducibility: guidelines from the Kidney Precision Medicine Project

Authors :
Rachel Sealfon
Evren U. Azeloglu
Jian Zhou
Tara K. Sigdel
Paul Hoover
Sanjay Jain
Yongqun He
Vivette D. D'Agati
Tarek M. El-Achkar
Blue B. Lake
Andrew Schroeder
Zoltan Laszik
Olga G. Troyanskaya
Jonas M Carson
Kumar Sharma
Edgar A. Otto
Samir M. Parikh
Guanshi Zhang
Rajasree Menon
Jeffrey B. Hodgin
Laura Barisoni
Habib Hamidi
Ravi Iyengar
Theodore Alexandrov
Pierre C. Dagher
Kun Zhang
Christopher Y. Park
Minnie M. Sarwal
Jinghui Luo
Marianinha Joanes
Dejan Dobi
Kenneth W. Dunn
Charles E. Alpers
Matthias Kretzler
Joseph P. Gaut
Christopher R. Anderton
Michael T. Eadon
Brad H. Rovin
Becky Steck
Seth Winfree
Source :
Physiol Genomics
Publication Year :
2020

Abstract

Comprehensive and spatially mapped molecular atlases of organs at a cellular level are a critical resource to gain insights into pathogenic mechanisms and personalized therapies for diseases. The Kidney Precision Medicine Project (KPMP) is an endeavor to generate three-dimensional (3-D) molecular atlases of healthy and diseased kidney biopsies by using multiple state-of-the-art omics and imaging technologies across several institutions. Obtaining rigorous and reproducible results from disparate methods and at different sites to interrogate biomolecules at a single-cell level or in 3-D space is a significant challenge that can be a futile exercise if not well controlled. We describe a “follow the tissue” pipeline for generating a reliable and authentic single-cell/region 3-D molecular atlas of human adult kidney. Our approach emphasizes quality assurance, quality control, validation, and harmonization across different omics and imaging technologies from sample procurement, processing, storage, shipping to data generation, analysis, and sharing. We established benchmarks for quality control, rigor, reproducibility, and feasibility across multiple technologies through a pilot experiment using common source tissue that was processed and analyzed at different institutions and different technologies. A peer review system was established to critically review quality control measures and the reproducibility of data generated by each technology before their being approved to interrogate clinical biopsy specimens. The process established economizes the use of valuable biopsy tissue for multiomics and imaging analysis with stringent quality control to ensure rigor and reproducibility of results and serves as a model for precision medicine projects across laboratories, institutions and consortia.

Details

ISSN :
15312267
Volume :
53
Issue :
1
Database :
OpenAIRE
Journal :
Physiological genomics
Accession number :
edsair.doi.dedup.....abb8cf401b5ec1e2fb2318ffc933ed98